Literature DB >> 23125312

Corticosteroids, heart failure, and hypertension: a role for immune cells?

Jimmy Z Shen1, Morag J Young.   

Abstract

Aldosterone and its receptor the mineralocorticoid receptor (MR) are best known for their regulation of fluid and electrolyte homeostasis in epithelial cells. However, it is now clear that MR are also expressed in a broad range of nonepithelial tissues including the cardiovascular system. In the heart and vascular tissues, pathological activation of MR promotes cardiovascular inflammation and remodeling for which there is increasing evidence that macrophages and other immune cells (e.g. T cells and dendritic cells) play a significant role. While the glucocorticoids and their receptors have well-described antiinflammatory actions in immune cells, a role for aldosterone and/or the MR in these cells is largely undefined. Emerging evidence, however, suggests that MR signaling may directly or indirectly promote proinflammatory responses in these immune cells. This review will discuss the current understanding of the role of corticosteroid receptors in macrophages and their effect on cardiovascular diseases involving inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125312     DOI: 10.1210/en.2012-1780

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.

Authors:  Guanghong Jia; Adam Whaley-Connell; James R Sowers
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

Review 2.  Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.

Authors:  Guanghong Jia; Yan Jia; James R Sowers
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-29       Impact factor: 5.187

Review 3.  The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.

Authors:  Guanghong Jia; Annayya R Aroor; James R Sowers
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

4.  Mineralocorticoid receptor is involved in the aldosterone pathway in human red blood cells.

Authors:  Luciana Bordin; Carlo Saccardi; Gabriella Donà; Chiara Sabbadin; Alessandra Andrisani; Guido Ambrosini; Mario Plebani; Anna Maria Brunati; Eugenio Ragazzi; Salvatore Gizzo; Decio Armanini
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  Effects of HIP in protection of HSP70 for stress-induced cardiomyocytes injury and its glucorticoid receptor pathway.

Authors:  Zhang ZhiQing; Wang XinXing; Gong Jingbo; Zhan Rui; Gao Xiujie; Zhao Yun; Wu Lei; Leng Xue; Qian LingJia
Journal:  Cell Stress Chaperones       Date:  2014-05-01       Impact factor: 3.667

Review 6.  Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.

Authors:  Guanghong Jia; Annayya R Aroor; Michael A Hill; James R Sowers
Journal:  Hypertension       Date:  2018-09       Impact factor: 10.190

Review 7.  Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration.

Authors:  Aaron H Wasserman; Manigandan Venkatesan; Aitor Aguirre
Journal:  Cells       Date:  2020-06-03       Impact factor: 6.600

8.  Mineralocorticoid receptor signaling reduces numbers of circulating human naïve T cells and increases their CD62L, CCR7, and CXCR4 expression.

Authors:  Luciana Besedovsky; Barbara Linz; Jan Born; Tanja Lange
Journal:  Eur J Immunol       Date:  2014-04-10       Impact factor: 5.532

Review 9.  Interfering with mineralocorticoid receptor activation: the past, present, and future.

Authors:  Anne M Dorrance
Journal:  F1000Prime Rep       Date:  2014-08-01

10.  Relationship of Genetic Polymorphisms of Aldosterone Synthase Gene Cytochrome P450 11B2 and Mineralocorticoid Receptors with Coronary Artery Disease in Taiwan.

Authors:  Chi-Hung Chou; Kwo-Chang Ueng; Shun-Fa Yang; Chih-Hsien Wu; Po-Hui Wang
Journal:  Int J Med Sci       Date:  2016-02-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.